SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.21660 http://doi.org/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660

刘师佺 , 周玉碧 , 李啟恩 , 等 . 基于德尔菲法的藏药“蒂达”药用资源和临床应用专家共识 [J ] . 中国药房 , 2021 , 32 ( 12 ): 1416 - 1420 .

LIU S Q , ZHOU Y B , LI Q E , et al. Expert consensus on the medicinal resources and clinical application of Tibetan medicine "dida" based on Delphi method [J ] . China Pharm , 2021 , 32 ( 12 ): 1416 - 1420 .

PODHORECKA M , IBANEZ B , DMOSZYŃSKA A . Metformin-its potential anti-cancer and anti-aging effects [J ] . Postepy Hig Med Dosw (Online) , 2017 , 71 ( 0 ): 170 - 175 .

ZHENG Z D , BIAN Y , ZHANG Y , et al. Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis [J ] . Cell Cycle , 2020 , 19 ( 10 ): 1089 - 1104 . DOI: 10.1080/15384101.2020.1743911 http://doi.org/10.1080/15384101.2020.1743911

GWINN D M , SHACKELFORD D B , EGAN D F , et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint [J ] . Mol Cell , 2008 , 30 ( 2 ): 214 - 226 . DOI: 10.1016/j.molcel.2008.03.003 http://doi.org/10.1016/j.molcel.2008.03.003

YENMIŞ G , BEŞLI N , YAPRAK SARAÇ E , et al. Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism [J ] . Turk J Med Sci , 2021 , 51 ( 2 ): 826 - 834 . DOI: 10.3906/sag-1908-112 http://doi.org/10.3906/sag-1908-112

SUI X B , XU Y H , WANG X , et al. Metformin: a novel but controversial drug in cancer prevention and treatment [J ] . Mol Pharm , 2015 , 12 ( 11 ): 3783 - 3791 . DOI: 10.1021/acs.molpharmaceut.5b00577 http://doi.org/10.1021/acs.molpharmaceut.5b00577 https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00577 https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5b00577

LI M , HU X W , XU Y Q , et al. A possible mechanism of metformin in improving insulin resistance in diabetic rat models [J ] . Int J Endocrinol , 2019 , 2019 : 3248527 .

SUN R , ZHAI R , MA C , et al. Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway [J ] . Cancer Med , 2020 , 9 ( 3 ): 1141 - 1151 . DOI: 10.1002/cam4.2723 http://doi.org/10.1002/cam4.2723 https://onlinelibrary.wiley.com/doi/10.1002/cam4.2723 https://onlinelibrary.wiley.com/doi/10.1002/cam4.2723

LV Z Q , GUO Y J . Metformin and its benefits for various diseases [J ] . Front Endocrinol (Lausanne) , 2020 , 11 : 191 . DOI: 10.3389/fendo.2020.00191 http://doi.org/10.3389/fendo.2020.00191 https://www.frontiersin.org/article/10.3389/fendo.2020.00191/full https://www.frontiersin.org/article/10.3389/fendo.2020.00191/full

LIU Q L , TONG D L , LIU G L , et al. Metformin inhibits prostate cancer progression by targeting tumor-associated inflammatory infiltration [J ] . Clin Cancer Res , 2018 , 24 ( 22 ): 5622 - 5634 . DOI: 10.1158/1078-0432.CCR-18-0420 http://doi.org/10.1158/1078-0432.CCR-18-0420

KURELAC I , UMESH GANESH N , IORIO M , et al. The multifaceted effects of metformin on tumor microenvironment [J ] . Semin Cell Dev Biol , 2020 , 98 : 90 - 97 . DOI: S1084-9521(19)30077-1 http://doi.org/S1084-9521(19)30077-1

YE J , CHEN K , QI L , et al. Metformin suppresses hypoxia-induced migration via the HIF-1α/VEGF pathway in gallbladder cancer in vitro and in vivo [J ] . Oncol Rep , 2018 , 40 ( 6 ): 3501 - 3510 .

ORECCHIONI S , REGGIANI F , TALARICO G , et al. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells [J ] . Int J Cancer , 2015 , 136 ( 6 ): E534 -E544. DOI: 10.1002/ijc.29193 http://doi.org/10.1002/ijc.29193 https://onlinelibrary.wiley.com/doi/10.1002/ijc.29193 https://onlinelibrary.wiley.com/doi/10.1002/ijc.29193

ZHOU X K , CHEN J T , YI G , et al. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma [J ] . Oncotarget , 2016 , 7 ( 1 ): 873 - 884 . DOI: 10.18632/oncotarget.6418 http://doi.org/10.18632/oncotarget.6418

AHMED Z S O , GOLOVOY M , ABDULLAH Y , et al. Repurposing of metformin for cancer therapy: updated patent and literature review [J ] . Recent Pat Anticancer Drug Discov , 2021 , 16 ( 2 ): 161 - 186 . DOI: 10.2174/1574892816666210615163417 http://doi.org/10.2174/1574892816666210615163417

MALLIK R , CHOWDHURY T A . Metformin in cancer [J ] . Diabetes Res Clin Pract , 2018 , 143 : 409 - 419 . DOI: 10.1016/j.diabres.2018.05.023 http://doi.org/10.1016/j.diabres.2018.05.023 https://linkinghub.elsevier.com/retrieve/pii/S0168822717314109 https://linkinghub.elsevier.com/retrieve/pii/S0168822717314109

ROOS J F , QUDSI M , SAMARA A , et al. Metformin for lung cancer prevention and improved survival: a novel approach [J ] . Eur J Cancer Prev , 2019 , 28 ( 4 ): 311 - 315 . DOI: 10.1097/CEJ.0000000000000442 http://doi.org/10.1097/CEJ.0000000000000442

CEJUELA M , MARTIN-CASTILLO B , MENENDEZ J A , et al. Metformin and breast cancer: where are we now? [J ] . Int J Mol Sci , 2022 , 23 ( 5 ): 2705 . DOI: 10.3390/ijms23052705 http://doi.org/10.3390/ijms23052705 https://www.mdpi.com/1422-0067/23/5/2705 https://www.mdpi.com/1422-0067/23/5/2705

NG C A W , JIANG A A , TOH E M S , et al. Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression [J ] . Int J Colorectal Dis , 2020 , 35 ( 8 ): 1501 - 1512 . DOI: 10.1007/s00384-020-03676-x http://doi.org/10.1007/s00384-020-03676-x https://doi.org/10.1007/s00384-020-03676-x https://doi.org/10.1007/s00384-020-03676-x

ZAIDI S , GANDHI J , JOSHI G , et al. The anticancer potential of metformin on prostate cancer [J ] . Prostate Cancer Prostatic Dis , 2019 , 22 ( 3 ): 351 - 361 . DOI: 10.1038/s41391-018-0085-2 http://doi.org/10.1038/s41391-018-0085-2 https://doi.org/10.1038/s41391-018-0085-2 https://doi.org/10.1038/s41391-018-0085-2

COURTOIS S , LEHOURS P , BESSÈDE E . The therapeutic potential of metformin in gastric cancer [J ] . Gastric Cancer , 2019 , 22 ( 4 ): 653 - 662 . DOI: 10.1007/s10120-019-00952-w http://doi.org/10.1007/s10120-019-00952-w

MA S J , ZHENG Y X , ZHOU P C , et al. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis [J ] . Oncotarget , 2016 , 7 ( 40 ): 66202 - 66211 . DOI: 10.18632/oncotarget.11033 http://doi.org/10.18632/oncotarget.11033 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.11033 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.11033

LENG W , JIANG J , CHEN B , et al. Metformin and malignant tumors: not over the hill [J ] . Diabetes Metab Syndr Obes , 2021 , 14 : 3673 - 3689 . DOI: 10.2147/DMSO.S326378 http://doi.org/10.2147/DMSO.S326378 https://www.dovepress.com/metformin-and-malignant-tumors-not-over-the-hill-peer-reviewed-fulltext-article-DMSO https://www.dovepress.com/metformin-and-malignant-tumors-not-over-the-hill-peer-reviewed-fulltext-article-DMSO

LI Y , HU L Y , XIA Q H , et al. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis [J ] . Int Urol Nephrol , 2017 , 49 ( 6 ): 975 - 981 . DOI: 10.1007/s11255-017-1548-4 http://doi.org/10.1007/s11255-017-1548-4

LIU C Q , SUN J X , XU J Z , et al. Metformin use on incidence and oncologic outcomes of bladder cancer patients with T2DM: an updated meta-analysis [J ] . Front Pharmacol , 2022 , 13 : 865988 . DOI: 10.3389/fphar.2022.865988 http://doi.org/10.3389/fphar.2022.865988 https://www.frontiersin.org/articles/10.3389/fphar.2022.865988/full https://www.frontiersin.org/articles/10.3389/fphar.2022.865988/full

AHMED M F , KANAAN G , MOSTAFA J A . The role of metformin in ovarian cancer: does metformin increase survival in ovarian neoplasm? [J ] . Cureus , 2021 , 13 ( 2 ): e13100 .

BIONDANI G , PEYRON J F . Metformin, an anti-diabetic drug to target leukemia [J ] . Front Endocrinol (Lausanne) , 2018 , 9 : 446 . DOI: 10.3389/fendo.2018.00446 http://doi.org/10.3389/fendo.2018.00446 https://www.frontiersin.org/article/10.3389/fendo.2018.00446/full https://www.frontiersin.org/article/10.3389/fendo.2018.00446/full

JAUNE E , ROCCHI S . Metformin: focus on melanoma [J ] . Front Endocrinol (Lausanne) , 2018 , 9 : 472 . DOI: 10.3389/fendo.2018.00472 http://doi.org/10.3389/fendo.2018.00472 https://www.frontiersin.org/article/10.3389/fendo.2018.00472/full https://www.frontiersin.org/article/10.3389/fendo.2018.00472/full

MU N , XU T , GAO M , et al. Therapeutic effect of metformin in the treatment of endometrial cancer [J ] . Oncol Lett , 2020 , 20 ( 5 ): 156 . DOI: 10.3892/ol.2020.12017 http://doi.org/10.3892/ol.2020.12017

MAZUREK M , LITAK J , KAMIENIAK P , et al. Metformin as potential therapy for high-grade glioma [J ] . Cancers (Basel) , 2020 , 12 ( 1 ): E210 .

LIU B L , FAN Z Y , EDGERTON S M , et al. Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions [J ] . Cell Cycle , 2011 , 10 ( 17 ): 2959 - 2966 .

QU C , ZHANG W , ZHENG G , et al. Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells [J ] . Mol Cell Biochem , 2014 , 386 ( 1/2 ): 63 - 71 . DOI: 10.1007/s11010-013-1845-x http://doi.org/10.1007/s11010-013-1845-x http://link.springer.com/10.1007/s11010-013-1845-x http://link.springer.com/10.1007/s11010-013-1845-x

RAO M Y , GAO C L , GUO M , et al. Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis [J ] . Cancer Manag Res , 2018 , 10 : 4881 - 4890 . DOI: 10.2147/CMAR.S174535 http://doi.org/10.2147/CMAR.S174535

SAMSURI N A B , LEECH M , MARIGNOL L . Metformin and improved treatment outcomes in radiation therapy-a review [J ] . Cancer Treat Rev , 2017 , 55 : 150 - 162 . DOI: 10.1016/j.ctrv.2017.03.005 http://doi.org/10.1016/j.ctrv.2017.03.005 https://linkinghub.elsevier.com/retrieve/pii/S0305737217300427 https://linkinghub.elsevier.com/retrieve/pii/S0305737217300427

WRIGHT A D , CULL C A , MACLEOD K M , et al. Hypoglycemia in type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73 [J ] . J Diabetes Complications , 2006 , 20 ( 6 ): 395 - 401 . DOI: 10.1016/j.jdiacomp.2005.08.010 http://doi.org/10.1016/j.jdiacomp.2005.08.010 https://linkinghub.elsevier.com/retrieve/pii/S1056872705001194 https://linkinghub.elsevier.com/retrieve/pii/S1056872705001194

MCCREIGHT L J , STAGE T B , CONNELLY P , et al. Pharmacokinetics of metformin in patients with gastrointestinal intolerance [J ] . Diabetes Obes Metab , 2018 , 20 ( 7 ): 1593 - 1601 . DOI: 10.1111/dom.13264 http://doi.org/10.1111/dom.13264

SOUKAS A A , HAO H B , WU L F . Metformin as anti-aging therapy: is it for everyone? [J ] . Trends Endocrinol Metab , 2019 , 30 ( 10 ): 745 - 755 . DOI: 10.1016/j.tem.2019.07.015 http://doi.org/10.1016/j.tem.2019.07.015 https://linkinghub.elsevier.com/retrieve/pii/S104327601930147X https://linkinghub.elsevier.com/retrieve/pii/S104327601930147X

LENG W L , PU D L , JIANG J , et al. Effect of metformin on breast density in overweight/obese premenopausal women [J ] . Diabetes Metab Syndr Obes , 2021 , 14 : 4423 - 4432 . DOI: 10.2147/DMSO.S330625 http://doi.org/10.2147/DMSO.S330625 https://www.dovepress.com/effect-of-metformin-on-breast-density-in-overweightobese-premenopausal-peer-reviewed-fulltext-article-DMSO https://www.dovepress.com/effect-of-metformin-on-breast-density-in-overweightobese-premenopausal-peer-reviewed-fulltext-article-DMSO

HIGURASHI T , HOSONO K , TAKAHASHI H , et al. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial [J ] . Lancet Oncol , 2016 , 17 ( 4 ): 475 - 483 . DOI: S1470-2045(15)00565-3 http://doi.org/S1470-2045(15)00565-3

SUNG H , FERLAY J , SIEGEL R L , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.21660 http://doi.org/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660 https://onlinelibrary.wiley.com/doi/10.3322/caac.21660

TSENG C H . Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes [J ] . Breast Cancer Res Treat , 2014 , 145 ( 3 ): 785 - 790 . DOI: 10.1007/s10549-014-2985-8 http://doi.org/10.1007/s10549-014-2985-8 http://link.springer.com/10.1007/s10549-014-2985-8 http://link.springer.com/10.1007/s10549-014-2985-8

CHEN L , CHUBAK J , BOUDREAU D M , et al. Diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis [J ] . Cancer Res , 2017 , 77 ( 21 ): 6033 - 6041 . DOI: 10.1158/0008-5472.CAN-17-0687 http://doi.org/10.1158/0008-5472.CAN-17-0687

TANG G H , SATKUNAM M , POND G R , et al. Association of metformin with breast cancer incidence and mortality in patients with type Ⅱ diabetes: a GRADE-assessed systematic review and meta-analysis [J ] . Cancer Epidemiol Biomark Prev , 2018 , 27 ( 6 ): 627 - 635 . DOI: 10.1158/1055-9965.EPI-17-0936 http://doi.org/10.1158/1055-9965.EPI-17-0936 https://aacrjournals.org/cebp/article/27/6/627/71589/Association-of-Metformin-with-Breast-Cancer https://aacrjournals.org/cebp/article/27/6/627/71589/Association-of-Metformin-with-Breast-Cancer

CHLEBOWSKI R T , MCTIERNAN A , WACTAWSKI-WENDE J , et al. Diabetes, metformin, and breast cancer in postmenopausal women [J ] . J Clin Oncol , 2012 , 30 ( 23 ): 2844 - 52 . DOI: 10.1200/JCO.2011.39.7505 http://doi.org/10.1200/JCO.2011.39.7505

PARK Y M M , BOOKWALTER D B , O’BRIEN K M , et al. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer [J ] . Ann Oncol , 2021 , 32 ( 3 ): 351 - 359 . DOI: 10.1016/j.annonc.2020.12.008 http://doi.org/10.1016/j.annonc.2020.12.008

CHEN H J , COOK L S , TANG M C , et al. Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer [J ] . Cancer Epidemiol Biomarkers Prev , 2019 , 28 ( 11 ): 1802 - 1808 . DOI: 10.1158/1055-9965.EPI-19-0291 http://doi.org/10.1158/1055-9965.EPI-19-0291 https://aacrjournals.org/cebp/article/28/11/1802/167466/Relationship-between-Diabetes-and-Diabetes https://aacrjournals.org/cebp/article/28/11/1802/167466/Relationship-between-Diabetes-and-Diabetes

BAYRAKTAR S , HERNADEZ-AYA L F , LEI X D , et al. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer [J ] . Cancer , 2012 , 118 ( 5 ): 1202 - 1211 . DOI: 10.1002/cncr.26439 http://doi.org/10.1002/cncr.26439

DHILLON S S , GROMAN A , MEAGHER A , et al. Metformin and not diabetes influences the survival of resected early stage NSCLC patients [J ] . J Cancer Sci Ther , 2014 , 6 ( 7 ): 217 - 222 .

XU T B , LI D S , HE Y , et al. Prognostic value of metformin for non-small cell lung cancer patients with diabetes [J ] . World J Surg Oncol , 2018 , 16 ( 1 ): 60 . DOI: 10.1186/s12957-018-1362-1 http://doi.org/10.1186/s12957-018-1362-1

XU T , LIANG G , YANG L , et al. Prognosis of small cell lung cancer patients with diabetes treated with metformin [J ] . Clin Transl Oncol , 2015 , 17 ( 10 ): 819 - 824 . DOI: 10.1007/s12094-015-1311-1 http://doi.org/10.1007/s12094-015-1311-1

KONG F M , GAO F F , LIU H G , et al. Metformin use improves the survival of diabetic combined small-cell lung cancer patients [J ] . Tumour Biol , 2015 , 36 ( 10 ): 8101 - 8106 . DOI: 10.1007/s13277-015-3549-1 http://doi.org/10.1007/s13277-015-3549-1 http://link.springer.com/10.1007/s13277-015-3549-1 http://link.springer.com/10.1007/s13277-015-3549-1

KANG J H , JEONG S M , SHIN D W , et al. The associations of aspirin, statins, and metformin with lung cancer risk and related mortality: a time-dependent analysis of population-based nationally representative data [J ] . J Thorac Oncol , 2021 , 16 ( 1 ): 76 - 88 . DOI: 10.1016/j.jtho.2020.08.021 http://doi.org/10.1016/j.jtho.2020.08.021

ZENG S , GAN H X , XU J X , et al. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: a meta-analysis [J ] . Med Clin (Barc) , 2019 , 152 ( 8 ): 291 - 297 . DOI: 10.1016/j.medcli.2018.06.026 http://doi.org/10.1016/j.medcli.2018.06.026 https://linkinghub.elsevier.com/retrieve/pii/S0025775318304494 https://linkinghub.elsevier.com/retrieve/pii/S0025775318304494

BRANCHER S , STØER N C , WEIDERPASS E , et al. Metformin use and lung cancer survival: a population-based study in Norway [J ] . Br J Cancer , 2021 , 124 ( 5 ): 1018 - 1025 . DOI: 10.1038/s41416-020-01186-9 http://doi.org/10.1038/s41416-020-01186-9 https://doi.org/10.1038/s41416-020-01186-9 https://doi.org/10.1038/s41416-020-01186-9

BRADLEY M C , FERRARA A , ACHACOSO N , et al. A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus [J ] . Cancer Epidemiol Biomarkers Prev , 2018 , 27 ( 5 ): 525 - 530 . DOI: 10.1158/1055-9965.EPI-17-0424 http://doi.org/10.1158/1055-9965.EPI-17-0424 https://aacrjournals.org/cebp/article/27/5/525/71475/A-Cohort-Study-of-Metformin-and-Colorectal-Cancer https://aacrjournals.org/cebp/article/27/5/525/71475/A-Cohort-Study-of-Metformin-and-Colorectal-Cancer

FERNANDES J M , JANDREY E H F , KOYAMA F C , et al. Metformin as an alternative radiosensitizing agent to 5-fluorouracil during neoadjuvant treatment for rectal cancer [J ] . Dis Colon Rectum , 2020 , 63 ( 7 ): 918 - 926 . DOI: 10.1097/DCR.0000000000001626 http://doi.org/10.1097/DCR.0000000000001626

XIE J Y , XIA L P , XIANG W , et al. Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1 [J ] . Proc Natl Acad Sci USA , 2020 , 117 ( 23 ): 13012 - 13022 . DOI: 10.1073/pnas.1918845117 http://doi.org/10.1073/pnas.1918845117 https://pnas.org/doi/full/10.1073/pnas.1918845117 https://pnas.org/doi/full/10.1073/pnas.1918845117

FRANSGAARD T , THYGESEN L C , GÖGENUR I . Association between metformin use after surgery for colorectal cancer and oncological outcomes: a nationwide register-based study [J ] . Int J Cancer , 2018 , 143 ( 1 ): 63 - 72 . DOI: 10.1002/ijc.31305 http://doi.org/10.1002/ijc.31305

MC MENAMIN Ú C , MURRAY L J , HUGHES C M , et al. Metformin use and survival after colorectal cancer: a population-based cohort study [J ] . Int J Cancer , 2016 , 138 ( 2 ): 369 - 379 . DOI: 10.1002/ijc.29720 http://doi.org/10.1002/ijc.29720

KASPER J S , GIOVANNUCCI E . A meta-analysis of diabetes mellitus and the risk of prostate cancer [J ] . Cancer Epidemiol Biomarkers Prev , 2006 , 15 ( 11 ): 2056 - 2062 . DOI: 10.1158/1055-9965.EPI-06-0410 http://doi.org/10.1158/1055-9965.EPI-06-0410 https://aacrjournals.org/cebp/article/15/11/2056/275040/A-Meta-analysis-of-Diabetes-Mellitus-and-the-Risk https://aacrjournals.org/cebp/article/15/11/2056/275040/A-Meta-analysis-of-Diabetes-Mellitus-and-the-Risk

HANKINSON S J , FAM M , PATEL N N . A review for clinicians: prostate cancer and the antineoplastic properties of metformin [J ] . Urol Oncol , 2017 , 35 ( 1 ): 21 - 29 . DOI: S1078-1439(16)30316-7 http://doi.org/S1078-1439(16)30316-7

LEE M J , JAYALATH V H , XU W , et al. Association between metformin medication, genetic variation and prostate cancer risk [J ] . Prostate Cancer Prostatic Dis , 2021 , 24 ( 1 ): 96 - 105 . DOI: 10.1038/s41391-020-0238-y http://doi.org/10.1038/s41391-020-0238-y https://doi.org/10.1038/s41391-020-0238-y https://doi.org/10.1038/s41391-020-0238-y

MARGEL D , URBACH D R , LIPSCOMBE L L , et al. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes [J ] . J Clin Oncol , 2013 , 31 ( 25 ): 3069 - 3075 . DOI: 10.1200/JCO.2012.46.7043 http://doi.org/10.1200/JCO.2012.46.7043

TSENG C H . Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus [J ] . Eur J Cancer , 2014 , 50 ( 16 ): 2831 - 2837 . DOI: 10.1016/j.ejca.2014.08.007 http://doi.org/10.1016/j.ejca.2014.08.007 https://linkinghub.elsevier.com/retrieve/pii/S0959804914008867 https://linkinghub.elsevier.com/retrieve/pii/S0959804914008867

YANG B , DAMODARAN S , KHEMEES T A , et al. Synthetic lethal metabolic targeting of androgen-deprived prostate cancer cells with metformin [J ] . Mol Cancer Ther , 2020 , 19 ( 11 ): 2278 - 2287 . DOI: 10.1158/1535-7163.MCT-19-1141 http://doi.org/10.1158/1535-7163.MCT-19-1141

ZHOU X L , XUE W H , DING X F , et al. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies [J ] . Oncotarget , 2017 , 8 ( 33 ): 55622 - 55631 . DOI: 10.18632/oncotarget.16973 http://doi.org/10.18632/oncotarget.16973 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.16973 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.16973

TSENG C H . Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus [J ] . Aging (Albany NY) , 2016 , 8 ( 8 ): 1636 - 1649 .

CHEUNG K S , CHAN E W , WONG A Y S , et al. Metformin use and gastric cancer risk in diabetic patients after helicobacter pylori eradication [J ] . J Natl Cancer Inst , 2019 , 111 ( 5 ): 484 - 489 . DOI: 10.1093/jnci/djy144 http://doi.org/10.1093/jnci/djy144

LEE C K , JUNG M , JUNG I , et al. Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy [J ] . Ann Surg , 2016 , 263 ( 1 ): 96 - 102 . DOI: 10.1097/SLA.0000000000001086 http://doi.org/10.1097/SLA.0000000000001086 https://journals.lww.com/00000658-201601000-00016 https://journals.lww.com/00000658-201601000-00016

KIM J , HYUN H J , CHOI E A , et al. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database [J ] . Gastric Cancer , 2020 , 23 ( 6 ): 1075 - 1083 . DOI: 10.1007/s10120-020-01085-1 http://doi.org/10.1007/s10120-020-01085-1 https://doi.org/10.1007/s10120-020-01085-1 https://doi.org/10.1007/s10120-020-01085-1

DONADON V , BALBI M , GHERSETTI M , et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease [J ] . World J Gastroenterol , 2009 , 15 ( 20 ): 2506 - 2511 . DOI: 10.3748/wjg.15.2506 http://doi.org/10.3748/wjg.15.2506 http://www.wjgnet.com/1007-9327/full/v15/i20/2506.htm http://www.wjgnet.com/1007-9327/full/v15/i20/2506.htm

DONADON V , BALBI M , MAS M D , et al. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease [J ] . Liver Int , 2010 , 30 ( 5 ): 750 - 758 . DOI: 10.1111/j.1478-3231.2010.02223.x http://doi.org/10.1111/j.1478-3231.2010.02223.x

LEE M S , HSU C C , WAHLQVIST M L , et al. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800 000 individuals [J ] . BMC Cancer , 2011 , 11 : 20 . DOI: 10.1186/1471-2407-11-20 http://doi.org/10.1186/1471-2407-11-20 http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-11-20 http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-11-20

SHANKARAIAH R C , CALLEGARI E , GUERRIERO P , et al. Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma [J ] . Oncogene , 2019 , 38 ( 45 ): 7035 - 7045 . DOI: 10.1038/s41388-019-0942-z http://doi.org/10.1038/s41388-019-0942-z

FERLAY J , COLOMBET M , SOERJOMATARAM I , et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [J ] . Int J Cancer , 2019 , 144 ( 8 ): 1941 - 1953 . DOI: 10.1002/ijc.31937 http://doi.org/10.1002/ijc.31937

BOKHMAN J V . Two pathogenetic types of endometrial carcinoma [J ] . Gynecol Oncol , 1983 , 15 ( 1 ): 10 - 17 .

LEE T Y , MARTINEZ-OUTSCHOORN U E , SCHILDER R J , et al. Metformin as a therapeutic target in endometrial cancers [J ] . Front Oncol , 2018 , 8 : 341 . DOI: 10.3389/fonc.2018.00341 http://doi.org/10.3389/fonc.2018.00341

WU J W , BOUDREAU D M , PARK Y , et al. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature [J ] . Expert Opin Drug Saf , 2014 , 13 ( 8 ): 1071 - 1099 . DOI: 10.1517/14740338.2014.926887 http://doi.org/10.1517/14740338.2014.926887

ZHANG Z J , LI S . The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis [J ] . Diabetes Obes Metab , 2014 , 16 ( 8 ): 707 - 710 . DOI: 10.1111/dom.12267 http://doi.org/10.1111/dom.12267

KO E M , WALTER P , JACKSON A , et al. Metformin is associated with improved survival in endometrial cancer [J ] . Gynecol Oncol , 2014 , 132 ( 2 ): 438 - 442 . DOI: 10.1016/j.ygyno.2013.11.021 http://doi.org/10.1016/j.ygyno.2013.11.021

HANNA R K , ZHOU C X , MALLOY K M , et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway [J ] . Gynecol Oncol , 2012 , 125 ( 2 ): 458 - 469 . DOI: 10.1016/j.ygyno.2012.01.009 http://doi.org/10.1016/j.ygyno.2012.01.009

ARIMA R , MARTTILA M , HAUTAKOSKI A , et al. Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrial cancer in women with type 2 diabetes [J ] . Anticancer Res , 2018 , 38 ( 7 ): 4169 - 4178 . DOI: 10.21873/anticanres.12710 http://doi.org/10.21873/anticanres.12710

URPILAINEN E , ARIMA R , KARIHTALA P , et al. Metformin associates with aggressive features of endometrial cancer in women with type 2 diabetes [J ] . Anticancer Res , 2021 , 41 ( 2 ): 821 - 828 . DOI: 10.21873/anticanres.14834 http://doi.org/10.21873/anticanres.14834

MEIRELES C G , PEREIRA S A , VALADARES L P , et al. Effects of metformin on endometrial cancer: Systematic review and meta-analysis [J ] . Gynecol Oncol , 2017 , 147 ( 1 ): 167 - 180 . DOI: S0090-8258(17)31136-8 http://doi.org/S0090-8258(17)31136-8

CHAE-KIM J , GARG G , GAVRILOVA-JORDAN L , et al. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis [J ] . Int J Gynecol Cancer , 2021 , 31 ( 12 ): 1499 - 1505 . DOI: 10.1136/ijgc-2021-002699 http://doi.org/10.1136/ijgc-2021-002699

YANG B Y , GULINAZI Y , DU Y , et al. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial [J ] . BJOG , 2020 , 127 ( 7 ): 848 - 857 . DOI: 10.1111/1471-0528.16108 http://doi.org/10.1111/1471-0528.16108 https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.16108 https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.16108

GONG H , CHEN Y , ZHOU D C . Prognostic significance of metformin treatment in endometrial cancer: a meta-analysis [J ] . Pharmazie , 2020 , 75 ( 8 ): 401 - 406 . DOI: 10.1691/ph.2020.0346 http://doi.org/10.1691/ph.2020.0346

TSENG C H . Metformin and biliary tract cancer in patients with type 2 diabetes [J ] . Front Oncol , 2020 , 10 : 587666 . DOI: 10.3389/fonc.2020.587666 http://doi.org/10.3389/fonc.2020.587666 https://www.frontiersin.org/articles/10.3389/fonc.2020.587666/full https://www.frontiersin.org/articles/10.3389/fonc.2020.587666/full

BOLEN S , FELDMAN L , VASSY J , et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus [J ] . Ann Intern Med , 2007 , 147 ( 6 ): 386 - 399 .

FUJITA Y , INAGAKI N . Metformin: new preparations and nonglycemic benefits [J ] . Curr Diab Rep , 2017 , 17 ( 1 ): 5 . DOI: 10.1007/s11892-017-0829-8 http://doi.org/10.1007/s11892-017-0829-8 http://link.springer.com/10.1007/s11892-017-0829-8 http://link.springer.com/10.1007/s11892-017-0829-8

KHURANA R , MALIK I S . Metformin: safety in cardiac patients [J ] . Postgrad Med J , 2010 , 86 ( 1016 ): 371 - 373 . DOI: 10.1136/hrt.2009.173773 http://doi.org/10.1136/hrt.2009.173773

NATHAN D M , BUSE J B , DAVIDSON M B , et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the study of diabetes [J ] . Diabetologia , 2009 , 52 ( 1 ): 17 - 30 . DOI: 10.1007/s00125-008-1157-y http://doi.org/10.1007/s00125-008-1157-y

TEALE K F , DEVINE A , STEWART H , et al. The management of metformin overdose [J ] . Anaesthesia , 1998 , 53 ( 7 ): 698 - 701 .

SELIGER C , MEYER A L , RENNER K , et al. Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2 [J ] . Cell Cycle , 2016 , 15 ( 13 ): 1755 - 1766 . DOI: 10.1080/15384101.2016.1186316 http://doi.org/10.1080/15384101.2016.1186316

YU Z Y , ZHAO G , XIE G F , et al. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo [J ] . Oncotarget , 2015 , 6 ( 32 ): 32930 - 32943 . DOI: 10.18632/oncotarget.5405 http://doi.org/10.18632/oncotarget.5405 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.5405 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.5405

SELIGER C , RENNER K , KREUTZ M , et al. p17.39 turn old into new: metformin as antineoplastic agent in glioblastoma [J ] . Neuro-Oncology , 2014 , 16 ( suppl 2 ): ii96 .

LIN H C , KACHINGWE B H , LIN H L , et al. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study [J ] . Pharmacotherapy , 2014 , 34 ( 1 ): 36 - 45 . DOI: 10.1002/phar.1334 http://doi.org/10.1002/phar.1334 https://onlinelibrary.wiley.com/doi/10.1002/phar.1334 https://onlinelibrary.wiley.com/doi/10.1002/phar.1334

Metformin: a practical guide to optimising outcomes round-table discussion held in Edinburgh [J ] . Br J Diabetes Vasc Dis , 2008 , 8 : 153 - 155 . DOI: 10.1177/14746514080080030801 http://doi.org/10.1177/14746514080080030801 http://journals.sagepub.com/doi/10.1177/14746514080080030801 http://journals.sagepub.com/doi/10.1177/14746514080080030801

HIRSCH H A , ILIOPOULOS D , TSICHLIS P N , et al. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission [J ] . Cancer Res , 2009 , 69 ( 19 ): 7507 - 7511 . DOI: 10.1158/0008-5472.CAN-09-2994 http://doi.org/10.1158/0008-5472.CAN-09-2994

ILIOPOULOS D , HIRSCH H A , STRUHL K . Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types [J ] . Cancer Res , 2011 , 71 ( 9 ): 3196 - 3201 . DOI: 10.1158/0008-5472.CAN-10-3471 http://doi.org/10.1158/0008-5472.CAN-10-3471

LIU H Y , SCHOLZ C , ZANG C B , et al. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro [J ] . Anticancer Res , 2012 , 32 ( 5 ): 1627 - 1637 .

CHATTERJEE S , THAKER N , DE A . Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells [J ] . Breast Cancer (Dove Med Press) , 2015 , 7 : 251 - 265 .

PENG M , DARKO K O , TAO T , et al. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms [J ] . Cancer Treat Rev , 2017 , 54 : 24 - 33 . DOI: S0305-7372(17)30005-1 http://doi.org/S0305-7372(17)30005-1

BRAGAGNOLI A C , ARAUJO R L C , FERRAZ M W , et al. Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial [J ] . Br J Cancer , 2021 , 124 ( 6 ): 1072 - 1078 . DOI: 10.1038/s41416-020-01208-6 http://doi.org/10.1038/s41416-020-01208-6 https://doi.org/10.1038/s41416-020-01208-6 https://doi.org/10.1038/s41416-020-01208-6

ROSHAN M H K , SHING Y K , PACE N P . Metformin as an adjuvant in breast cancer treatment [J ] . SAGE Open Med , 2019 , 7 : 2050312119865114 .

STOROZHUK Y , HOPMANS SN , SANLI T , et al. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK [J ] . Br J Cancer , 2013 , 108 ( 10 ): 2021 - 2032 . DOI: 10.1038/bjc.2013.187 http://doi.org/10.1038/bjc.2013.187 https://doi.org/10.1038/bjc.2013.187 https://doi.org/10.1038/bjc.2013.187

GULATI S , DESAI J , PALACKDHARRY S M , et al. Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer [J ] . Cancer , 2020 , 126 ( 2 ): 354 - 362 . DOI: 10.1002/cncr.32539 http://doi.org/10.1002/cncr.32539